Clincosm LogoSign in Get a demo

Multiple Myeloma

Showing NaN - NaN of 140
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Australia, United States (AMG 224)

Completed
Has Results
  • Multiple Myeloma
  • AMG 224
  • West Hollywood, California
  • +4 more
Oct 12, 2022

Multiple Myeloma Trial in Germany, United States (TNB-383B)

Recruiting
  • Multiple Myeloma
  • San Francisco, California
  • +14 more
Aug 22, 2022

Multiple Myeloma Trial in Worldwide (REGN5458)

Recruiting
  • Multiple Myeloma
  • Miami, Florida
  • +26 more
Aug 16, 2022

Advanced Cancer, Ovarian Cancer, Lung Cancer Trial in United States (Dose escalation: COM902 monotherapy., Evaluation of

Recruiting
  • Advanced Cancer
  • +6 more
  • Dose escalation: COM902 monotherapy.
  • +3 more
  • Grand Rapids, Michigan
  • +5 more
Aug 8, 2022

Multiple Myeloma Trial in United States (procedure, drug, biological)

Completed
Has Results
  • Multiple Myeloma
  • Tumor Cell Collection
  • +6 more
  • San Francisco, California
  • +14 more
Jul 11, 2022

Multiple Myeloma Trial in United States (Cilta-cel, Lymphodepleting Therapy (Cyclophosphamide and Fludarabine))

Recruiting
  • Multiple Myeloma
  • Cilta-cel
  • Lymphodepleting Therapy (Cyclophosphamide and Fludarabine)
  • Duarte, California
  • +23 more
Aug 1, 2022

Multiple Myeloma Trial in United States (Carfilzomib, Pomalidomide, Dexamethasone)

Terminated
  • Multiple Myeloma
  • Atlanta, Georgia
  • +8 more
Jul 28, 2022

Multiple Myeloma Trial in Worldwide (Belantamab mafodotin frozen liquid, Belantamab mafodotin lyophilized powder)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Belantamab mafodotin frozen liquid
  • Belantamab mafodotin lyophilized powder
  • New Haven, Connecticut
  • +58 more
Jul 27, 2022

NSCLC, Ovarian Cancer, Fallopian Tube Cancer Trial in United States (CART-TnMUC1, Cyclophosphamide, Fludarabine)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +5 more
  • CART-TnMUC1
  • +2 more
  • Phoenix, Arizona
  • +9 more
Jul 18, 2022

Multiple Myeloma, Plasma Cell Tumor, Malignant Plasma Cell Tumor Trial in Houston (Radiation Therapy)

Recruiting
  • Multiple Myeloma
  • +2 more
  • Radiation Therapy
  • Houston, Texas
    M D Anderson Cancer Center
Jul 9, 2022

Multiple Myeloma Trial in United States (bb2121, Fludarabine, Cyclophosphamide)

Active, not recruiting
  • Multiple Myeloma
  • bb2121
  • +3 more
  • Scottsdale, Arizona
  • +19 more
Jul 7, 2022

Multiple Myeloma, Refractory Multiple Myeloma Trial in Houston (Digital Health Coaching Program, Fitbit)

Recruiting
  • Multiple Myeloma
  • Refractory Multiple Myeloma
  • Digital Health Coaching Program
  • Fitbit
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Jun 17, 2022

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Mixed-Phenotype Leukemia Trial in United States (BMF-219)

Recruiting
  • Acute Myeloid Leukemia
  • +12 more
  • Los Angeles, California
  • +6 more
Jun 1, 2022

Lymphoma, Multiple Myeloma Trial in Worldwide (Lenalidomide, Dexamethasone, Dexamethasone (Oral))

Completed
Has Results
  • Lymphoma
  • Multiple Myeloma
  • Muscle Shoals, Alabama
  • +215 more
May 5, 2022

Acute Myeloid Leukemia, AML, Adult, Multiple Myeloma Trial in United States (FT538, Cyclophosphamide, Fludarabine)

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Denver, Colorado
  • +8 more
May 19, 2022

Multiple Myeloma Trial in United States (P-BCMA-101 CAR-T cells, Rimiducid)

Terminated
  • Multiple Myeloma
  • Gilbert, Arizona
  • +15 more
May 17, 2022

Advanced Solid Tumors, Lymphoma, Multiple Myeloma Trial in Nashville, Houston (AZD0466)

Terminated
  • Advanced Solid Tumors
  • +3 more
  • Nashville, Tennessee
  • +1 more
Apr 22, 2022

Hematological Malignancies, Multiple Myeloma, Hodgkin's Lymphoma Trial in Worldwide (Tinostamustine)

Recruiting
  • Hematological Malignancies
  • +3 more
  • Phoenix, Arizona
  • +19 more
Apr 12, 2022

Lymphoma, Lymphoma, B-Cell, Leukemia Trial in Houston (Digital Health Coaching)

Recruiting
  • Lymphoma
  • +6 more
  • Digital Health Coaching
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Apr 12, 2022

Multiple Myeloma, Non-Hodgkin Lymphoma, Indolent Non-Hodgkin Lymphoma Trial in United States (NKTR-255, NKTR-255 Q21, Rituximab)

Recruiting
  • Multiple Myeloma
  • +2 more
  • Goodyear, Arizona
  • +16 more
Mar 18, 2022

Multiple Myeloma, Plasma Cell Disorder Trial in Germany, United States (HDP-101)

Recruiting
  • Multiple Myeloma
  • Plasma Cell Disorder
  • Atlanta, Georgia
  • +5 more
Mar 10, 2022

Malignancy, Non-hodgkin Lymphoma, Multiple Myeloma Trial in United States (CYT-0851, CYT-0851 in combination with gemcitabine,

Recruiting
  • Malignancy
  • +14 more
  • Scottsdale, Arizona
  • +17 more
Mar 7, 2022

Presentation, Treatment Patterns, and Outcomes in Multiple

Completed
  • Multiple Myeloma
  • No Intervention
  • Little Rock, Arkansas
  • +136 more
Feb 15, 2022

Multiple Myeloma Trial in United States (Allogeneic HSCT, Fludarabine, Melphalan)

Completed
Has Results
  • Multiple Myeloma
  • Allogeneic HSCT
  • +5 more
  • Birmingham, Alabama
  • +14 more
Jan 25, 2022

Lung Cancer, Solid Tumor, Gastric Cancer Trial in Denmark, United States (Pemigatinib, Gemcitabine + Cisplatin, Pembrolizumab)

Completed
  • Lung Cancer
  • +10 more
  • Birmingham, Alabama
  • +19 more
Jan 4, 2022